2023 Volume 49 - Canada Communicable Disease Report (CCDR)

ISSN: 1481-8531

2023 Volume 49

CCDR: Volume 49-4, April 2023: Children's Health and COVID-19

• Summary of the National Advisory Committee on Immunization (NACI) Statement— Recommendations on Fractional Influenza Vaccine Dosing in the Event of a Shortage: Pandemic preparedness
• Summary of the National Advisory Committee on Immunization (NACI) Statement—Recommendation on Repeated Seasonal Influenza Vaccination
• Resource use and disease severity of children hospitalized for COVID-19 versus multisystem inflammatory syndrome in children (MIS-C) in Canada
• Description of COVID-19 outbreaks in childcare facilities in Alberta, March 2020 to December 31, 2021
• SARS-CoV-2 vaccine acceptance among caregivers of children younger than five years of age: A cross-sectional survey in Toronto
• COVID-19 outbreak trends in Canada, 2021
• National epidemiological analysis of the association of COVID-19 vaccination and incidence of COVID-19 cases in Canada, January to August 2021
• Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children

CCDR: Volume 49-2/3, February/March 2023: Early Warning in Public Health

• Event-based surveillance: Providing early warning for communicable disease threats
• Wastewater surveillance for earlier detection of seniors congregate living COVID-19 outbreaks in Peterborough, Ontario
• Utility of the Peterborough Public Health COVID-19 rapid antigen test self-report tool: Implications for COVID-19 surveillance
• Quality over quantity in active tick surveillance: Sentinel surveillance outperforms risk-based surveillance for tracking tick-borne disease emergence in southern Canada
• Community-based COVID-19 outbreak of the B.1.1.7 (Alpha) variant of concern in Newfoundland, February to March 2021
• Integration of hospital with congregate care homes in response to the COVID-19 pandemic
• Treatment of severe human mpox virus infection with tecovirimat: A case series
• Summary of the NACI Statement on Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-valent and 20-valent Conjugate Vaccines
• Update on mpox (monkeypox) in Canada, March 2023

CCDR Volume 49-1, January 2023: Literature Surveillance on COVID-19

• Rabies in an imported dog, Ontario, Canada, 2022
• COVID-19 literature surveillance—A framework to manage the literature and support evidence-based decision-making on a rapidly evolving public health topic
• National influenza mid-season report, 2022–2023: A rapid and early epidemic onset
• Novel six-month all oral treatment of pre-extensively drug-resistant tuberculosis in Canada: New treatment options present new implementation challenges
• Pertussis epidemiology in Canada, 2005–2019